Chamber and committees

It is important to make sure that the start date of the annual flu programme reflects the expected peak of flu circulating to ensure maximum vaccine efficacy.

The 2024 Winter Flu and Covid programme (FVCV) launched on 9 September with the child flu programme. This was the earliest the programme in Scotland could start the child programme, due to vaccine supply deliveries.

Vaccination of adult flu groups began on 16 September, with the main flu and COVID-19 co-administration launching on 23 September. As per previous winter programme, Boards used the first two weeks of the main programme to focus on our most vulnerable citizens, notably residents in care homes for older adults and the housebound. Community appointments then began on 7 October.

These launch dates were based on two factors;

1.Advice from the Joint Committee on Vaccination & Immunisation (JCVI): The JCVI advice noted that Health Departments should ideally aim to vaccinate their adult flu population in October and November, in order to vaccinate the eligible population prior to the beginning of the flu season, and to minimise the impact of vaccine waning.

2.Availability of COVID-19 vaccine supply: The vast majority of COVID-19 and flu vaccines are co-administered (currently 95.2% as of 26 January), for maximum convenience for people who are eligible for both. As such we had to wait for COVID-19 vaccine supplies to be available in Scotland to start that main phase of the programme, and 23 September was the earliest possible date.

During planning for its winter programmes, the Scottish Vaccination & Immunisation Programme (SVIP) takes multiple, complex factors into account when arriving at programme dates. These include JCVI advice on programme timings and cohort eligibility, the risk of emerging new COVID-19 variants, flu and COVID-19 vaccine supply availability and clinic capacity within the system.

These factors change annually, meaning that programme start dates will shift and therefore a direct comparison is difficult.

We are exploring a new long term conditions strategy to better recognise the fact that many people living with long term conditions need the same types of support and care, regardless of their condition. The strategy will focus on ensuring equitable and sustainable access to the services that all people with long term conditions need, while still allowing for targeted action on condition-specific care and support where appropriate.

We will shortly launch a full public consultation on this strategy. We are therefore not yet in a position to confirm the implications of the consultation and ensuing strategy with regard to condition-specific action plans.

The following table shows the breakdown of this winter’s COVID-19 and flu vaccination uptake that was achieved as of 1 December 2024, broken down by Health Board. The table also shows the uptake as a percentage for the whole for Scotland.

This data is publicly accessible via the Public Health Scotland (PHS) Open Source website: Flu & COVID vaccinations - Datasets - Scottish Health and Social Care Open Data

Uptake as of 1 December 2024:

The Scottish Government does not hold this information. The Scottish Cardiac Audit Programme publishes data on heart disease mortality including information on deaths under 65. Data is available at: Scottish Cardiac Audit Programme report 2023/2024 - Scottish Cardiac Audit Programme (SCAP) - Publications - Public Health Scotland.

Health Boards are responsible for delivery of Scotland’s vaccination programmes, unless there are exceptional circumstances. This approach enables GP practices to focus on what only they can do.

The Scottish Government has agreed with NHS Highland that due to exceptional circumstances there, a mixed model of vaccine delivery can be put in place. This will be a hybrid model for vaccine delivery in which NHS Highland will also continue to provide some vaccination programmes.

The Scottish Government draft budget 2025-26 has been informed by planning forecasts provided by the Thrombectomy Advisory Group (TAG). Clinicians and third sector organisations, as well as NHS planning colleagues, are represented on the TAG and the information provided by them helps to inform decisions taken by the National Thrombectomy Programme Board.

Work is ongoing to establish how the £16 million funding announced in the Scottish budget, subject to parliamentary scrutiny, will be best used to maximise the number of patients able to benefit from thrombectomy.

It is forecast that £3.185m will have been spent by the end of March 2025 for activity related to the aims in the Neurological Care and Support in Scotland: A Framework for Action 2020 – 2025.

The Framework was published in 2019 and despite the extensive disruption to health and social care services during the pandemic, and accompanying pressure on Scottish Government and health board priorities, we sustained our focus and efforts to deliver the commitments of the Framework.

Actions will continue in the financial year 2025-26 for which the budget is still to be passed. We are asking Parliament to unite behind the Budget to ensure this funding reaches the people who need it.

The Scottish Government draft budget 2025-26 has been informed by planning forecasts provided by the Thrombectomy Advisory Group (TAG). Clinicians and third sector organisations, as well as NHS planning colleagues, are represented on the TAG and the information provided by them helps to inform decisions taken by the National Thrombectomy Programme Board.

Work is ongoing to establish how the £16 million funding announced in the Scottish budget, subject to parliamentary scrutiny, will be best used to maximise the number of patients able to benefit from thrombectomy.

Neurology trainees are provided with training in immunology and virology. The curriculum for neurology training, published by the Joint Royal Colleges of Physicians Training Board, includes Capabilities in Practice (CiPs) on managing inflammatory and infectious disorders.

These CiPs make clear expectations upon neurology trainees regarding:

• understanding of the underlying anatomy and pathophysiology of inflammatory and infectious diseases of the nervous system, including the treatments and their side effects
• ability to select, request and interpret relevant investigations including serology, genetic testing, imaging of the brain and spine, neurophysiology, tissue culture and histology in order to diagnose and manage such disorders
• ability to work with other relevant clinicians both in treating and monitoring patients and in referring them to other disciplines as appropriate.

There is robust educational Governance through NHS Education Scotland (NES) for neurology training in Scotland. NES does not consider it necessary to require neurologists to be experts in either immunology or virology, but to be able to clinically assess, investigate and manage people with neuroimmunological conditions and neuroinfectious disease using an evidence-based approach.